Gates Open Research | |
Introduction of subcutaneous depot medroxyprogesterone acetate through use of community-based distributors in Zambia | |
article | |
Elise Soerensen1  Namwinga Chintu2  John Phiri2  Gina M. Smith2  Felix Tembo2  Gertrude Silungwe2  Doris Ngosa Mwape2  George Katyetye2  Loyce Munthali4  Namuunda Mutombo2  Mwanjinga Mwale2  Handson Manda2  Hastings Moono2  Masauso Nqumayo2  | |
[1] Development Aid from People to People;Society for Family Health;Population Services International;United States Agency for International Development | |
关键词: Feasibility; Introduction; Distribution; DMPA-SC; Community level; Zambia; | |
DOI : 10.12688/gatesopenres.13020.2 | |
学科分类:电子与电气工程 | |
来源: American Journal Of Pharmtech Research | |
【 摘 要 】
Background: The majority of women in Sub-Saharan countries including Zambia use intramuscular Depot Medroxyprogesterone Acetate (DMPA IM) as their preferred method of contraception. However, nearly one-third of the women who start on DMPA IM discontinue within 12 months due to access barriers. Sayana® Press, low-dose, prefilled subcutaneous depot medroxyprogesterone acetate (DMPA-SC), suitable for even lower-level healthcare providers and potential for self-injection administration, has been developed. This pilot aimed to understand the feasibility of DMPA-SC in Zambia through use of community-based distributors (CBDs). Methods: The pilot was implemented from May 2017 to July 2017 in 29 public health facilities in three districts. A total of 161 CBDs received a comprehensive training in DMPA-SC, which included counselling about the method, potential side effects, correct administration and waste management. Post-training mentorship and supervision was conducted. Routine client level data was collected through Ministry of Health management information system. Results: During the pilot, 12,818 clients were provided with modern voluntary FP methods, with 16.4% (2,100) opting for DMPA-SC. The age range of clients opting for DMPA-SC was between 15 and 50 years, with an average of 31 years. Slightly less than half (43%) of DMPA-SC clients were adolescents and young women, with 11% aged 15–19 and 32% aged 20–24. No adverse events were reported during or immediately subsequent to the introduction of DMPA-SC administration by CBDs. Conclusion: The pilot demonstrated that CBDs can safely provide DMPA-SC at the community level with appropriate public sector coordination and oversight.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202307110001264ZK.pdf | 629KB | download |